Viewing Study NCT05280067

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-05-05 @ 1:48 PM
Study NCT ID: NCT05280067
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-20
First Post: 2022-01-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: ZETAMET™ BONE GRAFT IN THE REPAIR OF BONE DEFECTS FROM METASTATIC BREAST CANCER IN VERTEBRAL BONES
Sponsor: Zetagen Therapeutics, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer in the Spine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Breast Cancer View
None Bone Metastases View
None Spine Metastases View
None Vancouver View
None Metastatic Breast Cancer to Bone View
None X-radiation therapy View